| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Edwards Lifesciences Corporation (EW) has 10 insiders with recent SEC Form 4 filings, including 0 buys and 15 sells. EW is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Pres | 215.9K | $19.35M | - | |
| VP | 98.6K | $8.84M | -23,145 | |
| CFO | 46.7K | $4.19M | - | |
| VP | 44.3K | $3.97M | - | |
| VP | 40.4K | $3.62M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 23, 2021 | Mussallem Michael A65 | Chairman &CEO | Sale+OE | 68,550 | $84.17 | $5,769,920.68 | -5.8% | |
| Feb 16, 2021 | Szyman Catherine M.67 | Cvp, Critical Care | Sale+OE | 3,389 | $88.20 | $298,909.80 | -11.2% | |
| Feb 11, 2021 | Wang Huimin68 | Cvp, Japan &Intercontinental | Sale+OE | 11,745 | $86.81 | $1,019,583.45 | -11.2% | |
| Feb 5, 2021 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 13,077 | $85.80 | $1,121,996.14 | -21.2% | |
| Feb 4, 2021 | Valeriani Nicholas J | Director | Sale+OE | 8,200 | $85.21 | $698,752.34 | -12.1% | |
| Feb 1, 2021 | Lemercier Jean-Luc M67 | Cvp, Emea, Canada, Latin Amer | Sale+OE | 20,523 | $83.51 | $1,713,787.48 | -12.8% | |
| Jan 15, 2021 | Szyman Catherine M.67 | Cvp, Critical Care | Sale+OE | 3,389 | $87.27 | $295,758.03 | -11.2% | |
| Jan 15, 2021 | Wang Huimin68 | Cvp, Japan &Intercontinental | Sale+OE | 11,730 | $87.27 | $1,023,677.10 | -11.2% | |
| Jan 15, 2021 | Mussallem Michael A65 | Chairman &CEO | Sale+OE | 68,550 | $87.50 | $5,997,877.76 | -11.7% | |
| Jan 8, 2021 | Bobo Donald E Jr64 | Cvp,Strategy/ Corp Development | Sale+OE | 13,077 | $90.45 | $1,182,756.16 | -11.0% |